SCHEMBL26416014

SCHEMBL26416014

Cc1cc(O)ncc1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
FFAR4 Q5NUL3 1/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
STAT3 P40763 1/20 0.48
HTT P42858 1/20 0.48
CDK1 P06493 1/20 0.47
CCNB1 P14635 1/20 0.47
GSK3B P49841 1/20 0.47
CDK5 Q00535 1/20 0.47
CDK5R1 Q15078 1/20 0.47
LIPE Q05469 1/20 0.46
CYP2C19 P33261 2/20 0.44
CYP2C9 P11712 1/20 0.44
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
BRD4 O60885 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26415934 0.83 L3MBTL1 (0.53) MAPTTDP1L3MBTL1FFAR4MAPK1
SCHEMBL27579945 0.83 PDGFRB (0.52) SMN1; SMN2STAT3HTTCDK1CCNB1
SCHEMBL29965188 0.81 FFAR1 (0.50) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL23663288 0.81 MAPT (0.54) MAPTTDP1L3MBTL1FFAR4MAPK1
SCHEMBL24583106 0.81 MAPT (0.50) MAPTTDP1L3MBTL1FFAR4MAPK1
SCHEMBL23663274 0.81 FFAR1 (0.50) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL23663332 0.81 MAPT (0.50) MAPTTDP1L3MBTL1FFAR4MAPK1
SCHEMBL23691246 0.80 LMNA (0.50) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL25081934 0.79 MAPT (0.64) MAPTTDP1L3MBTL1FFAR4MAPK1
SCHEMBL22448645 0.78 GLRA1 (0.48) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780825-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE (SHANGHAI) CO., LTD. (CN) 2023-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780825-B2 Thyroid hormone receptor agonists and use thereof TSHR, THRA, THRB MAPT 112/4885TDP1 936/4885L3MBTL1 4551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.